These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 8910623)
1. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers. Sakamoto T; Nomura N; Mori H; Wake N Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623 [TBL] [Abstract][Full Text] [Related]
2. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830 [TBL] [Abstract][Full Text] [Related]
3. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma. McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210 [TBL] [Abstract][Full Text] [Related]
4. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152 [TBL] [Abstract][Full Text] [Related]
6. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351 [TBL] [Abstract][Full Text] [Related]
7. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216 [TBL] [Abstract][Full Text] [Related]
8. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer. Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563 [TBL] [Abstract][Full Text] [Related]
9. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546 [TBL] [Abstract][Full Text] [Related]
10. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Frankel RH; Bayona W; Koslow M; Newcomb EW Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252 [TBL] [Abstract][Full Text] [Related]
11. Detection of 17p loss in gastric carcinoma using polymerase chain reaction. Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854 [TBL] [Abstract][Full Text] [Related]
12. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Saxena A; Clark WC; Robertson JT; Ikejiri B; Oldfield EH; Ali IU Cancer Res; 1992 Dec; 52(23):6716-21. PubMed ID: 1358438 [TBL] [Abstract][Full Text] [Related]
13. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680 [TBL] [Abstract][Full Text] [Related]
15. Mutations in the p53 gene occur in diverse human tumour types. Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845 [TBL] [Abstract][Full Text] [Related]
16. [Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma]. Kniazev PG; Imianitov EN; Chernitsa OI; Nikiforova IF; Babenko VI; Bruderliaĭn S; Plutalo OV; Kuz'min AI; Kaboev OK; Berlin IuA Mol Biol (Mosk); 1992; 26(5):1134-47. PubMed ID: 1470178 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Jiang X; Hitchcock A; Bryan EJ; Watson RH; Englefield P; Thomas EJ; Campbell IG Cancer Res; 1996 Aug; 56(15):3534-9. PubMed ID: 8758923 [TBL] [Abstract][Full Text] [Related]
18. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014 [TBL] [Abstract][Full Text] [Related]
19. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and p53 gene mutations in breast cancer. Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]